HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon-Reference-Cited by-同舟云学术

HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon

Published:2008-01-23 Issue:10 Volume:122 Page:2233-2241
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Italiano Antoine,Bianchini Laurence,Keslair Frédérique,Bonnafous Stéphanie,Cardot-Leccia Nathalie,Coindre Jean-Michel,Dumollard Jean-Marc,Hofman Paul,Leroux Agnès,Mainguené Claire,Peyrottes Isabelle,Ranchere-Vince Dominique,Terrier Philippe,Tran Albert,Gual Philippe,Pedeutour Florence

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference45 articles.

1. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors;Pedeutour;Genes Chromosomes Cancer,1999

2. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data;Binh;Am J Surg Pathol,2005

3. Cloning of a novel transcription factor-like gene amplified in human glioma including astrocytoma grade I;Fischer;Hum Mol Genet,1997

4. Expression, cellular distribution and protein binding of the glioma amplified sequence (GAS41), a highly conserved putative transcription factor;Munnia;Oncogene,2001

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in histology specific treatments in soft tissue sarcoma;Expert Review of Anticancer Therapy;2024-08-05

2. Discovery of a dual-target DYRK2 and HDAC8 inhibitor for the treatment of hepatocellular carcinoma;Biomedicine & Pharmacotherapy;2024-08

3. An overview on liposarcoma subtypes: Genetic alterations and recent advances in therapeutic strategies;Journal of Molecular Histology;2024-05-02

4. Opportunity in Complexity: Harnessing Molecular Biomarkers and Liquid Biopsies for Personalized Sarcoma Care;Seminars in Radiation Oncology;2024-04

5. Polydopamine nanoparticles as a non-pharmaceutical tool in the treatment of fatty liver disease;Materials & Design;2024-03